New York Regional Center for Diabetes Translation Research

中心概况 纽约地区糖尿病转化研究中心（NY-CDTR）正在寻求 竞争性续约，以继续最大限度地提高致力于糖尿病翻译研究的资产， 高需求，文化多样性纽约地区。通过此应用程序，我们扩展了我们的服务，并提高了我们的 重点关注健康公平和健康的社会决定因素。NY-CDTR极大地扩展了资源， 支持糖尿病和肥胖症的2型转化研究，并促进进一步的合作努力， 尖端的翻译研究在整个纽约地区，与阿尔伯特爱因斯坦学院 医学作为这些努力的中心合作枢纽。我们的国家资源核心增强了我们的 在国家一级的影响，重点是糖尿病的预防和控制在美国拉丁裔人口。的 我们的多学科研究基地的内在力量和以患者和社区为中心的多样性 这些活动提供了一个综合平台，纽约-CDTR已经在这个平台上发展，并将继续扩展 强大的联系，利用我们的几个NIH资助的中心和机构资源。纽约的目标-- CDTR将继续改善和扩大现有服务的提供，开发创新的新服务， 并增加我们的转化研究基础的广度，重点关注健康公平和T3-T4转化 与多部门合作，开展针对弱势群体糖尿病健康公平性的研究项目 和多方利益攸关方合作伙伴。我们的成员增长，成果生产力和我们的研究基础 在我们的第一个融资期内，我们为持续的国家影响力做了非常好的准备。由我们中心指导 这些主题侧重于健康公平和生物心理社会方法，我们专注于这些具体目标： 1)促进现有的致力于2型糖尿病的杰出科学基地的成长和发展 与糖尿病及其并发症的预防和控制有关的转化研究， 管理四个转化研究核心，包括国家资源核心：a）行为科学 技术核心，B）生命过程方法核心，c）人口健康和保健系统 核心，d）拉丁裔糖尿病翻译研究网络：国家资源核心。2)促进 试点和可行性研究计划，支持启动糖尿病翻译研究计划， 提高新调查员的职业生涯。3)支持和组织一个丰富的计划， 可访问的优秀，现场和虚拟，互动，外部和内部研讨会，播客，教师/学员 两会4)提供一个行政核心，作为规划、执行和 评估研究、培训、资源和丰富活动方面的方案。5)扩展和整合 NY-CDTR与我们创新的拉丁美洲糖尿病翻译研究网络的科学努力 国家资源核心，从事研究人员领导美国国立卫生研究院资助的西班牙裔社区健康 研究/研究拉丁美洲人和其他资助拉丁美洲糖尿病翻译研究。

CENTER OVERVIEW The New York Regional Center for Diabetes Translation Research (NY-CDTR) is seeking is first competitive renewal in order to continue to maximize the assets devoted to diabetes translation research in the high-need, culturally diverse New York area. With this application, we expand our services and enhance our focus on health equity and social determinants of health. The NY-CDTR greatly expands the resources to support type 2 translational research on diabetes and obesity and foster further collaborative efforts to drive cutting-edge translational research throughout the New York region, with the Albert Einstein College of Medicine serving as a central collaborating hub for these efforts. Our National Resource Core enhances our impact on the national level with a focus on diabetes prevention and control in the US Latino population. The intrinsic strength of our multidisciplinary research base and diversity of patient- and community-centered activities provide an integrated platform upon which the NY-CDTR has developed and will continue to expand strong linkages, leveraging our several NIH-funded Centers and institutional resources. The goals of the NY- CDTR are to continue to improve and expand delivery of existing services, develop innovative new services and increase the breadth of our translational research base to focus on health equity and T3-T4 translational research projects targeting diabetes health equity in vulnerable populations in collaboration with multi-sector and multi-stakeholder partners. Our growth in membership, productivity in outcomes, and our research base over our first funding period positioned us extremely well for continued national impact. Guided by our Center themes that focus on health equity and a biopsychosocial approach, we focus on these Specific Aims: 1) To foster the growth and development of an existing outstanding scientific base devoted to type 2 translational research related to the prevention and control of diabetes and its complications by supporting and administering four translational research cores, including a National Resource Core: a) Behavioral Science and Technology Core, b) Life Course Methodology Core, c) Population Health and Health Systems Core, d) Latino Network for Diabetes Translation Research: A National Resource Core. 2) To promote a Pilot & Feasibility Study Program that supports initiation of diabetes translation research programs and enhances the careers of new investigators. 3) To support and organize an Enrichment Program by making accessible outstanding, live and virtual, interactive, external and internal seminars, podcasts, faculty/trainee conferences. 4) To provide an Administrative Core as the principal means of planning, implementing and evaluating the programs in research, training, resources and enrichment activities. 5) To expand and integrate the scientific efforts of the NY-CDTR with our innovative Latino Network for Diabetes Translation Research national resource core that engages investigators leading the NIH-funded Hispanic Community Health Study/Study of Latinos and others funded for Latino diabetes translation research.